Cognitive-behavioral therapy in panic disorder;Terapia cognitivo-comportamental no transtorno de pânico

Revista Brasileira de Psiquiatria

Volumn 30, Issue SUPPL. 2, 2008, Pages

  Manfro, Gisele Gus ^a,b   Heldt, Elizeth ^a,b   Cordioli, Aristides Volpato ^a,b   Otto, Michael W ^c  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c BOSTON UNIVERSITY   (United States)

Author keywords

Cognitive behavior therapy; Evidenced based efficacy; Panic disorder; Review; Treatment

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CYCLOSERINE;

ANXIETY; COGNITION; COGNITIVE THERAPY; COPING BEHAVIOR; DEPENDENT PERSONALITY DISORDER; HUMAN; INFORMATION PROCESSING; MEDICAL EDUCATION; MEDICAL LITERATURE; MEDLINE; OUTCOME ASSESSMENT; PANIC; PSYCHOPHARMACOLOGY; PSYCINFO; REVIEW; SYSTEMATIC REVIEW; THERAPY EFFECT; TREATMENT RESPONSE;

AGORAPHOBIA; ANTIMETABOLITES; COGNITIVE THERAPY; CYCLOSERINE; HUMANS; PANIC DISORDER; RECURRENCE; TREATMENT OUTCOME;

EID: 57349086237     PISSN: 15164446     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1516-44462008000600005     Document Type: Review

References (55)

1. APA, American Psychiatry Association. Manual Diagnóstico e Estatístico de Transtornos Mentais (DSM-IV-TR). 4a. ed. rev. Porto Alegre: Artmed; 2002.
2. Pollack MH, Marzol PC. Panic: course, complications and treatment of panic disorder. J Psychopharmacol. 2000;14(2 Suppl 1):S25-30.
3. Bruce SE, Yonkers KA, Otto MW, Eisen JL, Weisberg RB, Pagano M, Shea MT, Keller MB. Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective study. Am J Psychiatry. 2005;162(6):1179-87.
4. Sherbourne CD, Wells KB, Judd LL. Functioning and well-being of patients with panic disorder. Am J Psychiatry. 1996;153(2):213-8.
5. Mendlowicz MV, Stein MB. Quality of life in individuals with anxiety disorders. Am J Psychiatry. 2000;157(5):669-82.
6. Heldt E, Blaya C, Isolan L, Kipper L, Teruchkin B, Otto MW, Fleck M, Manfro GG. Quality of life and treatment outcome in panic disorder: cognitive-behavior therapy effects in patients refractory to medication treatment. Psychother Psychosom. 2006;75(3):183-6.
7. Kessler RC, Chiu WT, Jin R, Ruscio AM, Shear K, Walters EE. The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2006;63(4):415-24.
8. Roy-Byrne PP, Stein MD, Russo J, Mercier E, Thomas R, Mcquaid J, Katon WJ, Craske MG, Bystritsky A, Sherbourne CD. Panic disorder in the primary care setting: comorbidity, disability, service utilization and treatment. J Clin Psychiatry. 1999;60(7):492-9.
9. Manfro GG, Otto MW, Mcardle ET, Worthington JJ 3rd, Rosenbaum JF, Pollack MH. Relationship of antecedent stressful life events to childhood and family history of anxiety and the course of panic disorder. J Affect Disord. 1996;41(2):135-9.
10. Gould RA, Otto MW, Pollack MH. A meta-analysis of treatment outcome for panic disorder. Clin Psychol Rev. 1995;15:819-44.
11. Mitte K. A meta-analysis of the efficacy of psycho- and pharmacotherapy in panic disorder with and without agoraphobia. J Affect Disord. 2005;88(1):27-45.
12. Pollack MH. The pharmacotherapy of panic disorder. J Clin Psychiatry. 2005;66 Suppl 4:23-7.
13. Lydiard RB, Brawman-Mintzer O, Ballenger JC. Recent developments in the psychopharmacology of anxiety disorders. J Consult Clin Psychol. 1996;64(4):660-8.
14. Katschnig H, Amering M. The long-term course of panic disorder and its predictors. J Clin Psychopharmacol. 1998;18(6 Suppl 2):6s-11s.
15. Carpiniello B, Baita A, Carta MG, Sitzia R, Macciardi AM, Murgia S, Altamura AC. Clinical and psychosocial outcome of patients affected by panic disorder with or without agoraphobia: results from a naturalistic follow-up study. Eur Psychiatry. 2002;17(7):394-8.
16. Furukawa TA, Watanabe N, Chruchill R. Psychotherapy plus antidepressant for panic disorder with or without agoraphobia. Br J Psychiatry. 2006;188:305-12.
17. Otto MW, Deveney C. Cognitive-behavioral therapy and the treatment of panic disorder: efficacy and strategies. J Clin Psychiatry. 2005;66 Suppl 4:28-32.
18. Otto MW, Whittal ML. Cognitive-behavior therapy and longitudinal course of panic disorder. Psychiatr Clin North Am. 1995;18(4):803-20.
19. Black DW. Efficacy of combined pharmacotherapy and psychotherapy versus monotherapy and anxiolytics in the treatment of anxiety disorders. CNS Spectr. 2006;11(10 Suppl 12):29-33.
20. Telch MJ, Schmidt NB, Jaimez TL, Jacquin KM, Harrington PJ. Impact of cognitive-behavioral treatment on quality of life in panic disorder patients. J Consult Clin Psychol. 1995;63(5):823-30.
21. Tsao JC, Lewin MR, Craske MG. Effects of cognitive-behavior therapy for panic disorder on comorbid conditions: replication and extension. Behav Ther. 2002;33:493-509.
22. Clark DM. A cognitive approach to panic. Behav Res Ther. 1986;24(4):461-70.
23. Barlow DH. Anxiety and its disorders: the nature and treatment of anxiety and panic. New York: Guilford Press; 1988.
24. Manfro GG, Heldt E, Cordioli AV. Terapia cognitivo-comportamental no transtorno de pânico. In: Cordioli AV, organizador. Psicoterapias; abordagens atuais. 3a. ed. Porto Alegre: Artmed; 2008. p. 431-48.
25. Heldt E, Cordioli AV, Knijnik DZ, Manfro GG. Terapia cognitivo- comportamental em grupo para os transtornos de ansiedade. In: Cordioli AV, organizador. Psicoterapias; abordagens atuais. 3a. ed. Porto Alegre: Artmed; 2008. p. 317-37.
26. Craske MG, Roy-Byrne P, Stein MB, Sullivan G, Hazlett-Stevens H, Bystritsky A, Sherbourne C. CBT intensity and outcome for panic disorder in a primary care setting. Behav Ther. 2006;37(2):112-9.
27. Clark DM, Salkovskis PM, Hackmann A, Wells A, Ludgate J, Gelder M. Brief cognitive therapy for panic disorder: a randomized controlled trial. J Consult Clin Psychol. 1999;67(4):583-9.
28. Craske MG, Maidenberg E, Bystritsk A. Brief cognitive-behavioral versus nondirective therapy for panic disorder. J Behav Ther Exp Psychiatry. 1995;26(2):113-20.
29. Roy-Byrne PP, Craske MG, Stein MB, Sullivan G, Bystritsky A, Katon W, Golinelli D, Sherbourne CD. A randomized effectiveness trial of cognitive-behavioral therapy and medication for primary care panic disorder. Arch Gen Psychiatry. 2005;62(3):290-8.
30. Heldt E, Manfro GG, Kipper L, Blaya C, Malts S, Isolan L, Hirakaya VN, Otto MW. Treating medication-resistant panic disorder: predictors and outcome of cognitive-behavior therapy in a Brazilian public hospital. Psychother Psychosom. 2003;72(1):43-8.
31. Galassi F, Quercioli S, Charismas D, Niccolai V, Barciulli E. Cognitive-behavioral group treatment for panic disorder with agoraphobia. J Clin Psychol. 2007;63(4):409-16.
32. Schmidt NB, Wollaway-Bickel K, Trakowski JH, Santiago HT, Vasey M. Antidepressant discontinuation in the context of cognitive behavioral treatment for panic disorder. Behav Res Ther. 2002;40(1):67-73.
33. Powers MB, Smits JAJ, Leyro TM, Otto MW. Translational research perspectives on maximizing the effectiveness of exposure therapy. In: Richard DCS, Lauterbach DL, editors. Comprehensive Handbook of Exposure Therapies. Boston: Academic Press; 2006. p. 106-26.
34. Beck JS. Terapia cognitiva: teoria e prática. Porto Alegre: Artmed; 1997.
35. Wade SL, Monroe SM, Michelson LK. Chronic life stress and treatment outcome in agoraphobia with panic attacks. Am J Psychiatry. 1993;150(10):1491-5.
36. Heldt E. Terapia cognitivo-comportamental em grupo para pacientes com transtorno do pânico resistentes à medicação: preditores de resposta em até cinco anos de seguimento. Tese de Doutorado. UFRGS, 2006.
37. Lteif GN, Mavissakalian MR. Life events and panic disorder / agoraphobia. Compr Psychiatry. 1995;36(2):118-22.
38. Hofmann SG, Barlow DH, Papp LA, Detweiler MF, Ray SE, Shear MK, Woods SW, Gorman JM. Pretreatment attrition in a comparative treatment outcome study on panic disorder. Am J Psychiatry. 1998;155(1):43-7.
39. Penava SJ, Otto MW, Maki KM, Pollack MH. Rate of improvement during cognitive-behavioral group treatment for panic disorder. Behav Res Ther. 1998;36(7-8):665-73.
40. McHugh RK, Otto MW, Barlow DH, Gorman JM, Shear MK, Woods SW. Cost-efficacy of individual and combined treatments for panic disorder. J Clin Psychiatry. 2007;68(7):1038-44.
41. Heldt E, Gus Manfro G, Kipper L, Blaya C, Isolan L, Otto MW. One-year follow-up of pharmacotherapy-resistant patients with panic disorder treated with cognitive-behavior therapy: outcome and predictors of remission. Behav Res Ther. 2006;44(5):657-65.
42. Barlow DH, Gorman JM, Shear MK, Woods SW. Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: a randomized controlled trial. J Am Med Association. 2001;283:2529-36.
43. de Beurs E, van Balkom AJ, Lange A, Koele P, van Dyck R. Treatment of panic disorder with agoraphobia: comparison of fluvoxamine, placebo, and psychological panic management combined with exposure and of exposure in vivo alone. Am J Psychiatry. 1995;152(5):683-91.
44. Otto MW, Smits JA, Reese HE. Combined psychotherapy and pharmacotherapy for mood and anxiety disorders in adults: review and analysis. Clin Psycho Science Practice. 2005;12:72-86.
45. Otto MW, Hong JJ, Safren SA. Benzodiazepine discontinuation difficulties in panic disorder: conceptual model and outcome for cognitive-behavior therapy. Curr Pharm Des. 2002;8(1):75-80.
46. Whittal ML, Otto MW, Hong JJ. Cognitive-behavior therapy for discontinuation of SSRI treatment of panic disorder: a case series. Behav Res Ther. 2001;39(8):939-45.
47. Telch MJ, Agras WS, Taylor CB, Roth WT, Gallen C. Combined pharmacological and behavioral treatment for agoraphobia. Behav Res Ther. 1985;23(3):325-35.
48. Heuzenroeder L, Donnelly M, Haby MM, Mihalopoulos C, Rossell R, Carter R, Andrews G, Vos T. Cost-effectiveness of psychological and pharmacological interventions for generalized anxiety disorder and panic disorder. Aust N Z J Psychiatry. 2004;38(8):602-12.
49. Davis M. Role of NMDA receptors and MAP kinase in the amygdala in extinction of fear: clinical implications for exposure therapy. Eur J Neurosci. 2002;16(3):395-8.
50. Davis M, Meyers KM, Ressler KJ, Rothbaum BO. Facilitation of extinction of conditioned fear by d-cycloserine. Curr Dir Psychol Sci. 2005;14:214-9.
51. Richardson R, Ledgerwood L, Cranney J. Facilitation of fear extinction by D-cycloserine: Theoretical and clinical implications. Learn Mem. 2004;11(5):510-6.
52. Ressler KJ, Rothbaum BO, Tannenbaum L, Anderson P, Graap K, Zimand E, Hodges L, Davis M. Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear. Arch Gen Psychiatry. 2004;61(11):1136-44.
53. Norberg MM, Krystal JH, Tolin DF. A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy. Biol Psychiatry. 2008;63(12):1118-26.
54. Klein B, Richards JC, Austin DW. Efficacy of internet therapy for panic disorder. J Behav Ther Exp Psychiatry. 2006;37(3):213-38.
55. Deacon B, Abramowitz J. A pilot study of two-day cognitive-behavioral therapy for panic disorder. Behav Res Ther. 2006;44(6):807-17.